Canada Justin M, Thomas Georgia K, Trankle Cory R, Carbone Salvatore, Billingsley Hayley, Van Tassell Benjamin W, Evans Ronald K, Garten Ryan, Weiss Elisabeth, Abbate Antonio
1VCU Pauley Heart Center, Virginia Commonwealth University, P.O. Box 980335, 1200 E. Broad Street, Richmond, Virginia, 23298 USA.
2Department of Kinesiology & Health Sciences, College of Humanities & Sciences, Virginia Commonwealth University, Richmond, Virginia, USA.
Cardiooncology. 2020 Feb 28;6:2. doi: 10.1186/s40959-020-0058-1. eCollection 2020.
Irradiation of the heart during cancer radiotherapy is associated with a dose-dependent risk of heart failure. Animal studies have demonstrated that irradiation leads to an inflammatory response within the heart as well as a reduction in cardiac reserve. In the current study we aimed to evaluate whether inflammatory biomarkers correlated with changes in cardiac function and reserve after radiotherapy for breast or lung cancer.
We studied 25 subjects with a history of breast or lung cancer without a prior diagnosis of cardiovascular disease or heart failure, 1.8 years [0.4-3.6] post-radiotherapy involving at least 5 Gray (Gy) to at least 10% of the heart. High-sensitivity C-reactive protein (CRP) was abnormal (≥2 mg/L) in 16 (64%) subjects. Cardiac function and reserve was measured with Doppler echocardiography before and after exercise and defined as left-ventricular ejection fraction (LVEF), early diastolic mitral annulus velocity (e'), and increase in LV outflow tract velocity time integral cardiac output (cardiac reserve) with exercise. Subjects with abnormal CRP had significantly lower LVEF (51 [44-59] % vs 61 [52-64] %, = 0.039), lower e' (7.4 [6.6-7.9] cm/sec vs 9.9 [8.3-12.0] cm/sec, = 0.010), and smaller cardiac reserve (+ 1.5 [1.2-1.7] L/min vs + 1.9 [1.7-2.2] L/min, = 0.024).
Elevated systemic inflammation is associated with impaired left-ventricular systolic and diastolic function both at rest and during exercise in subjects who have received radiotherapy with significant incidental heart dose for the treatment of cancer.
癌症放疗期间对心脏进行照射与心力衰竭的剂量依赖性风险相关。动物研究表明,照射会导致心脏内的炎症反应以及心脏储备功能降低。在本研究中,我们旨在评估炎症生物标志物是否与乳腺癌或肺癌放疗后心脏功能和储备功能的变化相关。
我们研究了25例有乳腺癌或肺癌病史、既往未诊断为心血管疾病或心力衰竭的受试者,放疗后1.8年[0.4 - 3.6年],心脏至少10%接受了至少5格雷(Gy)的照射。16例(64%)受试者的高敏C反应蛋白(CRP)异常(≥2mg/L)。在运动前后用多普勒超声心动图测量心脏功能和储备功能,并将其定义为左心室射血分数(LVEF)、二尖瓣环舒张早期速度(e')以及运动时左心室流出道速度时间积分心输出量增加(心脏储备)。CRP异常的受试者的LVEF显著更低(51[44 - 59]%对61[52 - 64]%,P = 0.039),e'更低(7.4[6.6 - 7.9]cm/秒对9.9[8.3 - 12.0]cm/秒,P = 0.010),心脏储备更小(+1.5[1.2 - 1.7]L/分钟对+1.9[1.7 - 2.2]L/分钟,P = 0.024)。
在接受癌症放疗且心脏受到显著附带照射剂量的受试者中,全身炎症升高与静息和运动时左心室收缩和舒张功能受损相关。